Kaletra (PD-Rx Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Kaletra drug offered from PD-Rx Pharmaceuticals, Inc.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],UDP Glucuronosyltransferases Inducers [MoA],HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | PD-Rx Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Lopinavir and Ritonavir |
SUBSTANCE NAME: | LOPINAVIR; RITONAVIR |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],UDP Glucuronosyltransferases Inducers [MoA],HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-06-18 |
END MARKETING DATE: | 0000-00-00 |
Kaletra HUMAN PRESCRIPTION DRUG Details:
Item Description | Kaletra from PD-Rx Pharmaceuticals, Inc. |
LABELER NAME: | PD-Rx Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200; 50(mg/1; mg/1) |
START MARKETING DATE: | 2010-06-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55289-947_5aa4f1c7-3c0a-0f62-e053-2991aa0a094e |
PRODUCT NDC: | 55289-947 |
APPLICATION NUMBER: | NDA021906 |
Other LOPINAVIR; RITONAVIR Pharmaceutical Manufacturers / Labelers: